Continuing Medical Education
School of Medicine, UAB
   
Course Catalog
Back to Online Courses
Online CME Courses
Outpatient Evaluation and Management of Atrial Fibrillation, Part II


Certified for 1 AMA PRA Category 1 Credit


Co-Sponsored by the University of Alabama School of Medicine
Division of Continuing Medical Education and
The Alabama Quality Assurance Foundation

Release Date: March 5, 2007
Expiration Date: March 5, 2010

TARGET AUDIENCE:
Primary care physicians

OBJECTIVES:
Upon completion of this CME activity, clinicians should be able to:
  • Know the initial evaluation of patients with newly diagnosed atrial fibrillation and to identify secondary causes of atrial fibrillation.
  • Know the indications and management strategies for rate control vs. rhythm in patients with atrial fibrillation.
  • Understand how to stratify, know anti-thrombolic indications and management in patients with atrial fibrillation.
Top of Page

SOURCE:
FACULTY:

Carlos Estrada, MD
Associate Professor of Medicine
University of Alabama at Birmingham

Top of Page

DISCLOSURE:
Dr. Estrada has no commercial affiliations to disclose.
Top of Page

CME PARTICIPATION:
To participate in this program for CME credit, please review the objectives before beginning the program. Take the course, complete the case questions and evaluation before March 5, 2010 to receive CME credit. Your certificate will then be available online. This process should take approximately 60 minutes.

ACCREDITATION:

The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Alabama School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The boards of nursing in many states, including Alabama, recognize Category 1 continuing medical education courses as acceptable activities for the renewal of license to practice nursing.

Top of Page

DISCLAIMER: 
Dosages, indications, and methods of use of any drug referred to in this online course may reflect the clinical experience of the authors, clinical literature, or other clinical resources. Therefore, please see the full prescribing information before using any product mentioned.

INTRODUCTION:

This online course represents the second part of a series of two courses on the evaluation and management of Atrial Fibrillation.

Atrial fibrillation (AF) is a supraventricular arrhythmia characterized by uncoordinated atrial activation. The p wave is absent on EKG and the rhythm on the physical exam is usually irregular-irregular. The prevalence of atrial fibrillation increases with age. In apidemiological studies, the mortality is increased in patients with AF.[1]

Atrial fibrillation lasting more than 30 seconds can be:

  • Paroxysmal (recurrent episodes lasting 1-7 days)
  • Persistent (episodes lasting > 7 days, can be terminated by cardioversion)
  • Recurrent (>= 2 episodes)
  • Permanent (lasts > 1 year)
  • "Lone" (age < 60 years, no cardiac or pulmonary disease)

The above categories are not mutually exclusive, i.e.: a patient may have more than one category.[1]

The level of evidence indicated in the answers were reported in the ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation (highest to lowest):

  • Level of Evidence A: Data from multiple randomized cliical trials or meta-analyses.
  • Level of Evidence B: Data from a single randomized trial, or non-randomized studies.
  • Level of Evidence C: Only consensus opinion of experts, case studies, or standard-of-care.

Similarly, recommendations were classified[1] as:

  • Class I: Evidence available and/or general agreement that approach is beneficial.
  • Class II: Conflicting evidence and/or lack of agreement that approach is beneficial.
  • Class III: Evidence available and/or general agreement that approach is NOT beneficial.
Top of Page

Case 3:

A 77-year-old man returns to your office for routine follow-up without any complaints. He has a history of hypertension, diabetes, and hyperlipidemia. His medications include hydrochlorothiazide, enalapril, glucophage, and a statin. His health maintenance is up-to-date. On physical examination, his blood pressure is 138/88 mmHg and his pulse is 76/min. You notice that his pulse is irregular –irregular. The rest of his physical examination is normal. He has not had palpitations, dyspnea, or lightheadedness. He performs his daily activities without difficulties. His electrocardiogram reveals atrial fibrillation (rate 80/min) and left ventricular hyperthrophy. The laboratory examination, including blood count, liver profile, cholesterol, urinalysis, electrolytes, and creatinine are normal.

Top of Page

Case 3, Question 1 of 6

1. Which of the following is the next best step to take for this patient ?

A. Do nothing else, having him return for routine follow-up.
B. Refer him to cardiology for an electrophysiologic study.
C. Adjust his medications to reach a BP goal of <130/80 mmHg.
D. Consider anti-thrombotic therapy.




Refer to Friend Refer to Friend